Medical/Pharmaceuticals
MILVIK Launches COVID-19 Insurance and Telemedicine Bundle in Bangladesh
DHAKA, Bangladesh, Aug. 17, 2021 /PRNewswire/ -- Global healthcare and
insurtech providerMILVIK
2021-08-17 10:00
3983
Angel Pharmaceuticals Announces IND Acceptance for Clinical Trial of ITK Inhibitor CPI-818 in China
JIAXING, China and BURLINGAME, Calif., Aug. 16, 2021 /PRNewswire/ -- Angel Pharmaceuticals Ltd. ("Angel Pharma") today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted its IND application for the initiation of a Phase 1/...
2021-08-17 05:00
2201
Under the Patronage of His Highness Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Abu Dhabi Early Childhood Authority's WED Movement Engages Global Experts to Drive Innovation, Excellence in Early Childhood Development
ABU DHABI, UAE, Aug. 17, 2021 /PRNewswire/ -- Abu Dhabi's World Early Childhood Development Movement (WED Movement) has launched a new initiative bringing together global experts to develop innovative and actionable solutions advancing Abu Dhabi's vision to be a leader in Early Childhood Developme...
2021-08-17 00:51
4380
Tikomed's ILB® attenuates clinical symptoms and serum biomarkers of oxidative/nitrosative stress and mitochondrial dysfunction in ALS patients, data published by the Journal of Personalized Medicine
VIKEN, Sweden, Aug. 16, 2021 /PRNewswire/ -- New study results for Tikomed's platform lead drug candidate ILB® in the treatment of patients with amyotrophic lateral sclerosis (ALS), have now been published in the Journal of Personalized Medicine. The data revealed a significant normalization of t...
2021-08-16 22:32
1930
First Edition of World Conference on Early Detection of Cancer Set to Start in November in Hainan, China
GUANGZHOU and HAIKOU, China, Aug. 16, 2021 /PRNewswire/ -- Early detection and diagnosis of cancer is an essential enabler of curative treatment and an effective solution to boost the survival rates of cancer patients worldwide. In an effort to lead the way in innovative research and strategies f...
2021-08-16 22:13
2472
InferVision AI Assists the European Commission Monitoring COVID-19 Variants
WIESBADEN, Germany, Aug. 16, 2021 /PRNewswire/ -- InferVision AI has been selected to help monitor COVID-19 variants across the European Union. Faced with this challenge, the European Commission decided to increase their investment in the adoption of AI tools from InferVision. InferVision's AI to...
2021-08-16 21:51
5040
Ascletis' Partner Sagimet Dosed First Patient in FASCINATE-2 Phase IIb Trial in NASH Patients with Moderate to Advanced Fibrosis
HANGZHOU and SHAOXING, China, Aug. 16, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672) today announces that its partner Sagimet Biosciences dosed the first patient in its FASCINATE-2 Phase IIb clinical trial for non-alcoholic steatohepatitis (NASH). FASCINATE-2 is a randomized, double-blin...
2021-08-16 21:30
4548
Myungsung C&M launches a new MARPE
BUCHEON, South Korea, Aug. 16, 2021 /PRNewswire/ -- Myungsung C&M, a Korean
orthodontic product manufacturer, has recently released its new product, which
is A+ Expander as MARPE that Myungsung C&M introduces.
2021-08-16 21:00
2231
111, Inc. Deepens Partnership with Bayer Healthcare
SHANGHAI, Aug. 16, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced the expansion of its existing partnership with Baye...
2021-08-16 20:00
7462
Gracell Biotechnologies Signs Exclusive License Agreement with FutureGen Biopharm to Develop Engineered Immune Cell Therapies Targeting Claudin 18.2 in Solid Tumors
SUZHOU and SHANGHAI, China, and PALO ALTO, Calif., Aug. 16, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today ...
2021-08-16 20:00
3291
BioAgilytix to Purchase Australia-based 360biolabs®
Highly complementary transaction will strengthen company's ability to support bioanalytical services across all stages, development capabilities and geographies DURHAM, N.C., Aug. 16, 2021 /PRNewswire/ -- BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused ...
2021-08-16 18:00
4657
Senhwa Completes Enrollment of a Phase 2 Investigator Initiated Trial of Silmitasertib as Novel Oral Drug for COVID-19
TAIPEI and SAN DIEGO, Aug. 16, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focused on human efficacy and innovation of first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today announced that its novel oral drug, Silmita...
2021-08-16 15:29
2226
Introducing ProXmask(TM): Antiviral Face Mask as Better Alternative to Double-Masking and Capable of Inactivate SARS-CoV-2
KUALA LUMPUR, Malaysia, Aug. 16, 2021 /PRNewswire/ -- ProXmask™ is the first antiviral face mask mass-produced in theAsia Pacific by Prolexus Group. The antiviral face mask created by Prolexus Group is a remarkable example of conventional OEM (original equipment manufacturer) for globally renowne...
2021-08-16 15:21
3980
Occlutech granted important conditional FDA approval for PFO Study (OCCLUFLEX) in the U.S.
SCHAFFHAUSEN, Switzerland, Aug. 16, 2021 /PRNewswire/ -- Occlutech Holding AG ("Occlutech"), one of the world´s leading providers of minimally invasive structural heart disease devices, announces the conditional U.S. Food and Drug Administration ("FDA") approval of its Investigational Device Exem...
2021-08-16 14:00
2949
Sino Biological Announces Successful Closing of 4.98 Billion RMB Public Offering and Listing on the Shenzhen ChiNext Stock Exchange
BEIJING, Aug. 16, 2021 /PRNewswire/ -- Sino Biological, Inc. ("Sino Biological" or the "Company"), a biotechnology company which provides biological research reagents and related technical contract research services, announced a successful listing on the Shenzhen Stock Exchange subsidiary ChiNext...
2021-08-16 13:12
6784
GeneQuantum announces a key leadership appointment
SUZHOU, China, Aug. 15, 2021 /PRNewswire/ -- GeneQuantum Healthcare, an industry leading biopharmacetucial company dedicated to next generation bioconjugate drugs through innovative intelligent ligase-dependent conjugation (iLDC) technology platform, announced a key appointment to further strengt...
2021-08-16 10:00
1804
InnoCare Announces First Subject Dosed in Clinical Trial of ICP-332
BEIJING, Aug. 15, 2021 /PRNewswire/ -- InnoCare (HKEX: 09969), a leading biopharmaceutical company focusing on drug innovation for cancer and autoimmune diseases, announced today the first subject dosed in clinical trial of novel TYK2 (Tyrosine Kinase 2) inhibitor ICP-332 inChina. InnoCare disc...
2021-08-16 09:32
8427
InxMed's IN10018 Receives U.S. FDA Fast Track Designation for the Treatment of Platinum-resistant Ovarian Cancer
NANJING, China, Aug. 15, 2021 /PRNewswire/ -- InxMed (Nanjing) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, announced today the U.S. Food and Drug Administration (FDA) has granted Fas...
2021-08-16 09:31
2036
Arctic Vision Announces Expansion of License Territory for Suprachoroidal Space Injection Therapy ARVN001 to Include ASEAN Countries and India
SHANGHAI, Aug. 15, 2021 /PRNewswire/ -- Arctic Vision, a China-based biotech company focused on innovative ophthalmic therapies, announced today the entering of an amendment to the exclusive license agreement with its partner Clearside Biomedical, Inc. (Nasdaq: CLSD) ("Clearside"), to expand the ...
2021-08-16 08:00
8451
Innovent Announces Sintilimab in Combination with Chemotherapy Meets the Primary Endpoint of Overall Survival in the Phase 3 ORIENT-16 Study for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
SAN FRANCISCO and SUZHOU, China, Aug. 16, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
2021-08-16 08:00
7255
Week's Top Stories
Most Reposted
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
[Picked up by 309 media titles]
2026-07-30 10:45
J.P. Morgan Private Bank Earns Record 10 Accolades at The Asset Triple A Private Capital Awards 2026
[Picked up by 294 media titles]
2026-07-30 15:00KC Global Media announces new travel series "AXN Ultimate Challenge: Sarawak"
[Picked up by 291 media titles]
2026-07-30 09:12
ADA acquires Algonomy, strengthening its intelligent growth platform for a fully agentic experience
[Picked up by 290 media titles]
2026-07-30 15:30
Articura Launches a New Chapter for Sovereign Healthcare AI in Indonesia
[Picked up by 290 media titles]
2026-07-27 19:02
